Global Hormone Therapy Market Segments 2024, Forecast To 2033
5 Mar, 2024
The hormone therapy market has demonstrated strong growth, increasing from $18.58 billion in 2023 to $19.93 billion in 2024, with a 7.3% CAGR. The historic period's growth is linked to medical advancements, women's health revolution, awareness, clinical research, and shifting healthcare practices. Expecting strong growth, the market is projected to reach $26.49 billion in 2028 with a 7.4% CAGR. This growth is driven by personalized medicine, aging population, women's health shifts, wellness focus, and regulatory adaptations, accompanied by trends like regulatory changes and research advancements.
Global Hormone Therapy Market Key Driver
The hormone therapy market grows with the surge in hormone imbalance disorders, impacting 19% more people in 2022. London Medical Laboratory's report highlights the significance of hormone therapies in addressing hormonal imbalances, driving market growth.
Get A Free Sample Of The Global Hormone Therapy Market ReportGlobal Hormone Therapy Market Segments
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the hormone therapy market in 2023. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Hormone Therapy Industry Players
Abbott Laboratories; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche; Merck KGaA; Mylan NV; Novartis AG; Novo Nordisk AS; Pfizer Inc.; Abbvie Inc.; Teva Pharmaceutical Industries Ltd.; Perrigo Company Plc.; Cipla Inc.; Lupin Limited; Sun Pharmaceuticals Industries Ltd.; Hikma Pharmaceuticals PLC.; Johnsons & Johnsons Services Inc.; Boehringer Ingelheim International GmbH; Sanofi S.A.; AstraZeneca plc; TherapeuticsMD Inc.; Amgen Inc.; Genentech Inc.; Dr. Reddy's Laboratories Ltd; Allergan PLC; GlaxoSmithKline plc; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited; Astellas Pharma Inc.; Daiichi Sankyo Company Limited
Get The Full Global Hormone Therapy Market Report
AIOps Hormone Therapy Market Overview
Hormone therapy refers to a kind of treatment that alters, suppresses, or increases certain hormones in the body. Hormone therapy is used to treat hormonal imbalances such as hypothyroidism, and others.
Hormone Therapy Global Market Report 2023 provides data on the global hormone therapy market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hormone therapy market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.